Literature DB >> 29455188

Laboratory hemostasis: from biology to the bench.

Giuseppe Lippi1, Emmanuel J Favaloro2.   

Abstract

Physiological hemostasis is an intricate biological system, where procoagulant and anticoagulant forces interplay and preserves blood fluidity when blood vessels are intact, or trigger clot formation to prevent excessive bleeding when blood vessels are injured. The modern model of hemostasis is divided into two principal phases. The first, defined as primary hemostasis, involves the platelet-vessel interplay, whilst the second, defined as secondary hemostasis, mainly involves coagulation factors, damaged cells and platelet surfaces, where the so-called coagulation cascade rapidly develops. The activation and amplification of the coagulation cascade is finely modulated by the activity of several physiological inhibitors. Once bleeding has been efficiently stopped by blood clot formation, dissolution of the thrombus is essential to restore vessel permeability. This process, known as fibrinolysis, also develops through coordinate action of a vast array of proteins and enzymes. An accurate diagnosis of hemostasis disturbance entails a multifaceted approach, encompassing family and personal history of hemostatic disorders, accurate collection of clinical signs and symptoms, integrated with laboratory hemostasis testing. Regarding laboratory testing, a reasonable approach entails classifying hemostasis testing according to cost, complexity and available clinical information. Laboratory workout may hence initiate with some rapid and inexpensive "screening" tests, characterized by high negative predictive value, then followed by second- or third-line analyses, specifically aimed to clarify the nature and severity of bleeding or thrombotic phenotype. This article aims to provide a general overview of the hemostatic process, and to provide some general suggestions to optimally facilitate laboratory hemostasis testing.

Entities:  

Keywords:  bleeding; blood coagulation; laboratory hemostasis; platelets; thrombosis

Mesh:

Year:  2018        PMID: 29455188     DOI: 10.1515/cclm-2017-1205

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  7 in total

1.  Cryptogenic oozers and bruisers.

Authors:  Kristi J Smock; Karen A Moser
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 2.  Coronavirus Disease 2019-Associated Coagulopathy.

Authors:  Giuseppe Lippi; Fabian Sanchis-Gomar; Emmanuel J Favaloro; Carl J Lavie; Brandon M Henry
Journal:  Mayo Clin Proc       Date:  2020-10-31       Impact factor: 7.616

Review 3.  Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.

Authors:  Damiano D'Ardes; Andrea Boccatonda; Giulio Cocco; Stefano Fabiani; Ilaria Rossi; Marco Bucci; Maria Teresa Guagnano; Cosima Schiavone; Francesco Cipollone
Journal:  World J Gastroenterol       Date:  2022-03-21       Impact factor: 5.742

4.  Thrombin generation in different commercial sodium citrate blood tubes.

Authors:  Salvagno Gian Luca; Davide Demonte; Matteo Gelati; Giovanni Poli; Emmanuel J Favaloro; Giuseppe Lippi
Journal:  J Med Biochem       Date:  2020-01-10       Impact factor: 3.402

5.  D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis.

Authors:  Giuseppe Lippi; Emmanuel J Favaloro
Journal:  Thromb Haemost       Date:  2020-04-03       Impact factor: 5.249

6.  Project Management in Laboratory Medicine.

Authors:  Giuseppe Lippi; Camilla Mattiuzzi
Journal:  J Med Biochem       Date:  2019-07-30       Impact factor: 3.402

Review 7.  Vitamin K as a Diet Supplement with Impact in Human Health: Current Evidence in Age-Related Diseases.

Authors:  Dina C Simes; Carla S B Viegas; Nuna Araújo; Catarina Marreiros
Journal:  Nutrients       Date:  2020-01-03       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.